Gladius Capital Management’s Innoviva INVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-1,703
Closed -$32.9K 156
2024
Q3
$32.9K Sell
1,703
-398
-19% -$7.33K ﹤0.01% 188
2024
Q2
$34.5K Sell
2,101
-31
-1% -$481 ﹤0.01% 192
2024
Q1
$32.5K Sell
2,132
-339
-14% -$5.33K 0.01% 284
2023
Q4
$39.6K Buy
2,471
+301
+14% +$4.21K 0.01% 212
2023
Q3
$28.2K Sell
2,170
-245
-10% -$3.18K ﹤0.01% 311
2023
Q2
$30.7K Sell
2,415
-431
-15% -$5.39K ﹤0.01% 253
2023
Q1
$32K Sell
2,846
-65
-2% -$789 ﹤0.01% 279
2022
Q4
$38.6K Buy
2,911
+141
+5% +$1.85K ﹤0.01% 233
2022
Q3
$33K Sell
2,770
-189
-6% -$2.59K ﹤0.01% 285
2022
Q2
$44K Buy
+2,959
New +$48.5K ﹤0.01% 261

Other funds holding INVA

Gladius Capital Management's INVA Position: Q4 2024 in Review

Gladius Capital Management sold out of Innoviva (INVA) in Q4 2024, closing a stake of 1,703 shares — an estimated $32.9K sold.

Gladius Capital Management first reported a position in INVA in Q2 2022 and held it in 10 quarters. The position peaked at $44K in Q2 2022. 235 funds tracked by Wall St. Rank hold INVA as of Q4 2024.

  • Gladius Capital Management reported no remaining Innoviva position as of Q4 2024 after selling out during the quarter.
  • Gladius Capital Management sold 1,703 Innoviva shares in Q4 2024, an estimated $32.9K.
  • Gladius Capital Management first reported a position in Innoviva in Q2 2022 and held it in 10 quarters.
  • Gladius Capital Management's Innoviva position peaked at $44K in Q2 2022.
  • 235 funds tracked by Wall St. Rank held Innoviva as of Q4 2024.

Based on Gladius Capital Management's 13F filing for Q4 2024, filed 31 Jan 2025.